{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T14:06:34Z","timestamp":1792937194348,"version":"4.5.0"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.colsurfb.2025.115356","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T16:08:25Z","timestamp":1765210105000},"page":"115356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["ECM-responsive nanomedicine to enhance immunotherapy in pancreatic cancer"],"prefix":"10.1016","volume":"260","author":[{"given":"Li","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxiong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2025.115356_bib1","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1073\/pnas.1512603113","article-title":"Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer","volume":"113","author":"Saloman","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.colsurfb.2025.115356_bib2","doi-asserted-by":"crossref","first-page":"19609","DOI":"10.1073\/pnas.1908626116","article-title":"Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells","volume":"116","author":"Tian","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.colsurfb.2025.115356_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/science.abj0486","article-title":"Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis","volume":"373","author":"Del Poggetto","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.colsurfb.2025.115356_bib4","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2018.08.033","article-title":"Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features","volume":"155","author":"Puleo","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.colsurfb.2025.115356_bib5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00535-021-01800-4","article-title":"Molecular mechanisms of pancreatic myofibroblast activation in chronic pancreatitis and pancreatic ductal adenocarcinoma","volume":"56","author":"Cannon","year":"2021","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.colsurfb.2025.115356_bib6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1102\/1470-7330.2013.9012","article-title":"Mimics of pancreatic ductal adenocarcinoma","volume":"13","author":"Al-Hawary","year":"2013","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.colsurfb.2025.115356_bib7","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1016\/j.devcel.2024.07.021","article-title":"FRA1 controls acinar cell plasticity during murine Kras(G12D)-induced pancreatic acinar to ductal metaplasia","volume":"59","author":"Li","year":"2024","journal-title":"Dev. Cell"},{"key":"10.1016\/j.colsurfb.2025.115356_bib8","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/jso.26312","article-title":"Immunotherapy for pancreatic ductal adenocarcinoma","volume":"123","author":"Carpenter","year":"2021","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.colsurfb.2025.115356_bib9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jhbp.944","article-title":"Advances in immunotherapy for pancreatic ductal adenocarcinoma","volume":"28","author":"Miyazawa","year":"2021","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"10.1016\/j.colsurfb.2025.115356_bib10","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.3748\/wjg.v28.i27.3297","article-title":"Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy","volume":"28","author":"Smith","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.colsurfb.2025.115356_bib11","article-title":"Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma","volume":"11","author":"Schmiechen","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.colsurfb.2025.115356_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cytogfr.2022.09.001","article-title":"Fibroblast heterogeneity in pancreatic ductal adenocarcinoma: Perspectives in immunotherapy","volume":"68","author":"Luong","year":"2022","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.colsurfb.2025.115356_bib13","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","article-title":"Challenges and Opportunities for Pancreatic Cancer Immunotherapy","volume":"38","author":"Bear","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.colsurfb.2025.115356_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2020.06.011","article-title":"Neoantigen-based immunotherapy in pancreatic ductal adenocarcinoma (PDAC)","volume":"490","author":"Chen","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.colsurfb.2025.115356_bib15","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ccell.2024.02.017","article-title":"Mapping functional to morphological variation reveals the basis of regional extracellular matrix subversion and nerve invasion in pancreatic cancer","volume":"42","author":"Di Chiaro","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.colsurfb.2025.115356_bib16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","article-title":"Tumor microenvironment in pancreatic cancer pathogenesis and therapeutic resistance","volume":"18","author":"Sherman","year":"2023","journal-title":"Annu Rev. Pathol."},{"key":"10.1016\/j.colsurfb.2025.115356_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.612271","article-title":"Stroma involvement in pancreatic ductal adenocarcinoma: an overview focusing on extracellular matrix proteins","volume":"12","author":"Liot","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.colsurfb.2025.115356_bib18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.immuni.2017.07.014","article-title":"Tissue-resident macrophages in pancreatic ductal adenocarcinoma originate from embryonic hematopoiesis and promote tumor progression","volume":"47","author":"Zhu","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.colsurfb.2025.115356_bib19","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1152\/physrev.00042.2019","article-title":"Microenvironmental determinants of pancreatic cancer","volume":"100","author":"Hessmann","year":"2020","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.colsurfb.2025.115356_bib20","doi-asserted-by":"crossref","DOI":"10.1042\/EBC20243001","article-title":"Modulating immune cells within pancreatic ductal adenocarcinoma via nanomedicine","author":"Lin","year":"2025","journal-title":"Essays Biochem"},{"key":"10.1016\/j.colsurfb.2025.115356_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216138","article-title":"Regulation of metabolism in pancreatic ductal adenocarcinoma via nanotechnology-enabled strategies","volume":"560","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.colsurfb.2025.115356_bib22","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.7150\/thno.15122","article-title":"Interventional nanotheranostics of pancreatic ductal adenocarcinoma","volume":"6","author":"Li","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.colsurfb.2025.115356_bib23","first-page":"306","article-title":"Targeted drug delivery systems for pancreatic ductal adenocarcinoma: overcoming tumor microenvironment challenges with CAF-specific nanoparticles","volume":"3","author":"Su","year":"2023","journal-title":"J. Natl. Cancer Cent."},{"key":"10.1016\/j.colsurfb.2025.115356_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102033","article-title":"Nanoparticle-based therapeutic strategies for enhanced pancreatic ductal adenocarcinoma immunotherapy","volume":"14","author":"Hou","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2025.115356_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14010137","article-title":"Gene Therapy using nanocarriers for pancreatic ductal adenocarcinoma: applications and challenges in cancer therapeutics","volume":"14","author":"Won","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2025.115356_bib26","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ccell.2022.06.011","article-title":"Oncogenic collagen I homotrimers from cancer cells bind to \u03b13\u03b21 integrin and impact tumor microbiome and immunity to promote pancreatic cancer","volume":"40","author":"Chen","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.colsurfb.2025.115356_bib27","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41586-022-05169-z","article-title":"Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome","volume":"610","author":"Su","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.colsurfb.2025.115356_bib28","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1002\/ijc.32751","article-title":"Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer","volume":"146","author":"Chen","year":"2020","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.colsurfb.2025.115356_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cells11233763","article-title":"Type XXII collagen complements fibrillar collagens in the serological assessment of tumor fibrosis and the outcome in pancreatic cancer","volume":"11","author":"Madsen","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.colsurfb.2025.115356_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/MPA.0000000000001195","article-title":"Tenascin C, fibronectin, and tumor-stroma ratio in pancreatic ductal adenocarcinoma","volume":"48","author":"Lepp\u00e4nen","year":"2019","journal-title":"Pancreas"},{"key":"10.1016\/j.colsurfb.2025.115356_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12957-019-1574-z","article-title":"Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma","volume":"17","author":"Hu","year":"2019","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.colsurfb.2025.115356_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300787","article-title":"Visual investigation of tumor-promoting fibronectin potentiated by obesity in pancreatic ductal adenocarcinoma using an MR\/NIRF dual-modality dendrimer nanoprobe","volume":"12","author":"Xu","year":"2023","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.colsurfb.2025.115356_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mri.2021.11.008","article-title":"Magnetic resonance molecular imaging of extradomain B fibronectin enables detection of pancreatic ductal adenocarcinoma metastasis","volume":"86","author":"Qiao","year":"2022","journal-title":"Magn. Reson Imaging"},{"key":"10.1016\/j.colsurfb.2025.115356_bib34","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2478\/raon-2024-0020","article-title":"Correlation of laminin subunit alpha 3 expression in pancreatic ductal adenocarcinoma with tumor liver metastasis and survival","volume":"58","author":"Xing","year":"2024","journal-title":"Radio. Oncol."},{"key":"10.1016\/j.colsurfb.2025.115356_bib35","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/MPA.0000000000002154","article-title":"Clinically relevant biology of hyaluronic acid in the desmoplastic stroma of pancreatic ductal adenocarcinoma","volume":"51","author":"Jahedi","year":"2022","journal-title":"Pancreas"},{"key":"10.1016\/j.colsurfb.2025.115356_bib36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ccr.2012.01.007","article-title":"Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma","volume":"21","author":"Provenzano","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.colsurfb.2025.115356_bib37","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.colsurfb.2025.115356_bib38","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ccell.2024.03.005","article-title":"Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer","volume":"42","author":"Niu","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.colsurfb.2025.115356_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216859","article-title":"Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: challenges and opportunities","volume":"591","author":"Qin","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.colsurfb.2025.115356_bib40","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41419-022-05351-1","article-title":"Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.colsurfb.2025.115356_bib41","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41586-024-08508-4","article-title":"RNA neoantigen vaccines prime long-lived CD8(+) T cells in pancreatic cancer","volume":"639","author":"Sethna","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.colsurfb.2025.115356_bib42","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1136\/gutjnl-2022-329349","article-title":"CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-\u03baB\/p65 nuclear translocation in pancreatic ductal adenocarcinoma","volume":"72","author":"Liu","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.colsurfb.2025.115356_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002837","article-title":"DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma","volume":"9","author":"Fitzgerald","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.colsurfb.2025.115356_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adh9562","article-title":"Transcriptome-based identification of tumor-reactive and bystander CD8(+) T cell receptor clonotypes in human pancreatic cancer","volume":"15","author":"Meng","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.colsurfb.2025.115356_bib45","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/gutjnl-2022-327855","article-title":"IL-17A-producing CD8(+) T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts","volume":"72","author":"Picard","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.colsurfb.2025.115356_bib46","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.immuni.2022.01.006","article-title":"Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity","volume":"55","author":"Hezaveh","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.colsurfb.2025.115356_bib47","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-020-00958-3","article-title":"Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma","volume":"13","author":"Qian","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.colsurfb.2025.115356_bib48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ccell.2023.12.002","article-title":"EGFR-activated myofibroblasts promote metastasis of pancreatic cancer","volume":"42","author":"Mucciolo","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.colsurfb.2025.115356_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100793","article-title":"PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. A molecular imaging study","volume":"30","author":"Seki","year":"2022","journal-title":"Neoplasia"},{"key":"10.1016\/j.colsurfb.2025.115356_bib50","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41416-018-0246-z","article-title":"Galunisertib plus gemcitabine vsdot gemcitabine for first-line treatment of patients with unresectable pancreatic cancer","volume":"119","author":"Melisi","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.colsurfb.2025.115356_bib51","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41591-020-0880-x","article-title":"BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial","volume":"26","author":"Bockorny","year":"2020","journal-title":"Nat. Med"},{"key":"10.1016\/j.colsurfb.2025.115356_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104320","article-title":"Polysaccharides as therapeutic vehicles in pancreatic cancer","volume":"30","author":"Kumari","year":"2025","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.colsurfb.2025.115356_bib53","article-title":"Probiotics functionalized with a gallium-polyphenol network modulate the intratumor microbiota and promote anti-tumor immune responses in pancreatic cancer","volume":"15","author":"Han","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.colsurfb.2025.115356_bib54","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ccell.2023.04.001","article-title":"Simultaneous targeting of PD-1 and IL-2R\u03b2\u03b3 with radiation therapy inhibits pancreatic cancer growth and metastasis","volume":"41","author":"Piper","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.colsurfb.2025.115356_bib55","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003982","article-title":"Combination cancer immunotherapy targeting TNFR2 and PD-1\/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors","volume":"10","author":"Zhang","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.colsurfb.2025.115356_bib56","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.colsurfb.2025.115356_bib57","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1016\/j.ymthe.2023.07.021","article-title":"Targeting leucine-rich repeat serine\/threonine-protein kinase 2 sensitizes pancreatic ductal adenocarcinoma to anti-PD-L1 immunotherapy","volume":"31","author":"Sun","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.colsurfb.2025.115356_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217662","article-title":"Pancreatic cancer precursor lesions - Can immunotherapy prevent progression into pancreatic ductal adenocarcinoma?","volume":"619","author":"Enzler","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.colsurfb.2025.115356_bib59","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00262-017-2053-4","article-title":"CTLA-4\/CD80 pathway regulates T cell infiltration into pancreatic cancer","volume":"66","author":"Bengsch","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.colsurfb.2025.115356_bib60","doi-asserted-by":"crossref","first-page":"458","DOI":"10.21037\/jgo-22-587","article-title":"A rare case of sporadic mismatch repair deficient pancreatic ductal adenocarcinoma that responded to ipilimumab and nivolumab combination treatment: case report","volume":"14","author":"Han","year":"2023","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.colsurfb.2025.115356_bib61","doi-asserted-by":"crossref","first-page":"e808","DOI":"10.1634\/theoncologist.2019-0473","article-title":"Ipilimumab and Gemcitabine for advanced pancreatic cancer: a phase Ib study","volume":"25","author":"Kamath","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.colsurfb.2025.115356_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.947407","article-title":"Immune features of the peritumoral stroma in pancreatic ductal adenocarcinoma","volume":"13","author":"Ahmed","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.colsurfb.2025.115356_bib63","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1517\/13543784.2014.933206","article-title":"Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma","volume":"23","author":"Al Haddad","year":"2014","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.colsurfb.2025.115356_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2025.113015","article-title":"Lysosome-targeted theranostics: integration of real-time fluorescence imaging and controlled drug delivery via Zn(II)-Schiff Base complexes","volume":"272","author":"Lai","year":"2025","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.colsurfb.2025.115356_bib65","article-title":"Breaking hypoxic barrier: oxygen-supplied nanomaterials for enhanced T cell-mediated tumor immunotherapy","volume":"10","author":"Xiang","year":"2025","journal-title":"Int. J. Pharm. X"},{"key":"10.1016\/j.colsurfb.2025.115356_bib66","article-title":"Functional Dendrimer nanogels for DNA delivery and gene therapy of tumors","author":"Li","year":"2025","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"10.1016\/j.colsurfb.2025.115356_bib67","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1245\/s10434-024-16621-x","article-title":"Survival of patients with resected microsatellite instability-high, mismatch repair deficient, and lynch syndrome-associated pancreatic ductal adenocarcinomas","volume":"32","author":"Eikenboom","year":"2025","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.colsurfb.2025.115356_bib68","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1158\/1078-0432.CCR-22-0275","article-title":"Multi-omic characterization of pancreatic ductal adenocarcinoma relates CXCR4 mRNA expression levels to potential clinical targets","volume":"28","author":"Kocher","year":"2022","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.colsurfb.2025.115356_bib69","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/s41551-025-01389-6","article-title":"A biochemical sensor with continuous extended stability in vivo","volume":"9","author":"Chen","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.colsurfb.2025.115356_bib70","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1021\/acsnano.0c00974","article-title":"Enzyme-triggered transcytosis of dendrimer-drug conjugate for deep penetration into pancreatic tumors","volume":"14","author":"Wang","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.colsurfb.2025.115356_bib71","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62645","article-title":"Hyaluronic acid fuels pancreatic cancer cell growth","volume":"10","author":"Kim","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.colsurfb.2025.115356_bib72","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.7150\/jca.12990","article-title":"Receptor for hyaluronic acid-mediated motility is associated with poor survival in pancreatic ductal adenocarcinoma","volume":"6","author":"Cheng","year":"2015","journal-title":"J. Cancer"},{"key":"10.1016\/j.colsurfb.2025.115356_bib73","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9895721","article-title":"Expressions of matrix metalloproteinases 2, 7, and 9 in carcinogenesis of pancreatic ductal adenocarcinoma","volume":"2016","author":"Jakubowska","year":"2016","journal-title":"Dis. Markers"},{"key":"10.1016\/j.colsurfb.2025.115356_bib74","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/cas.16418","article-title":"Cancer-associated fibroblast-derived MMP11 promotes tumor progression in pancreatic cancer","volume":"116","author":"Wang","year":"2025","journal-title":"Cancer Sci."},{"key":"10.1016\/j.colsurfb.2025.115356_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70144","article-title":"Serum matrix metalloproteinase-7, Syndecan-1, and CA 19-9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma","volume":"13","author":"Yablecovitch","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.colsurfb.2025.115356_bib76","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2217\/epi.15.19","article-title":"The role of miR-21 and miR-211 on MMP9 regulation in pancreatic ductal adenocarcinoma: cooperation in invasiveness behaviors?","volume":"7","author":"Funel","year":"2015","journal-title":"Epigenomics"},{"key":"10.1016\/j.colsurfb.2025.115356_bib77","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.bbrc.2018.06.145","article-title":"SALL4 suppresses reactive oxygen species in pancreatic ductal adenocarcinoma phenotype via FoxM1\/Prx III axis","volume":"503","author":"Huynh","year":"2018","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.colsurfb.2025.115356_bib78","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.cmet.2024.03.015","article-title":"QDPR deficiency drives immune suppression in pancreatic cancer","volume":"36","author":"Liu","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.colsurfb.2025.115356_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103469","article-title":"Mitochondrial-targeted nanoparticles: delivery and therapeutic agents in cancer","volume":"28","author":"Ganji","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.colsurfb.2025.115356_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061501","article-title":"Glutathione S-Transferase pi-1 knockdown reduces pancreatic ductal adenocarcinoma growth by activating oxidative stress response pathways","volume":"12","author":"Singh","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.colsurfb.2025.115356_bib81","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.pan.2024.05.530","article-title":"SLC7A11 and the glutathione pathway as novel prognostic markers in resectable pancreatic ductal adenocarcinoma: a metabolomics study of clinical specimens","volume":"24","author":"Ohya","year":"2024","journal-title":"Pancreatology"},{"key":"10.1016\/j.colsurfb.2025.115356_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110341","article-title":"Folate-conjugated nanovehicles: strategies for cancer therapy","volume":"107","author":"Farran","year":"2020","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.colsurfb.2025.115356_bib83","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1158\/1535-7163.MCT-19-0556","article-title":"Hyaluronidase-expressing salmonella effectively targets tumor-associated hyaluronic acid in pancreatic ductal adenocarcinoma","volume":"19","author":"Ebelt","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.colsurfb.2025.115356_bib84","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.pan.2020.08.026","article-title":"Overexpression of transmembrane protein 2 (TMEM2), a novel hyaluronidase, predicts poor prognosis in pancreatic ductal adenocarcinoma","volume":"20","author":"Kudo","year":"2020","journal-title":"Pancreatology"},{"key":"10.1016\/j.colsurfb.2025.115356_bib85","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1136\/gutjnl-2024-332371","article-title":"CD64(+) fibroblast-targeted vilanterol and a STING agonist augment CLDN18.2 BiTEs efficacy against pancreatic cancer by reducing desmoplasia and enriching stem-like CD8(+) T cells","volume":"73","author":"Zhou","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.colsurfb.2025.115356_bib86","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.7150\/ijbs.107837","article-title":"Identification of a novel small molecule STING agonist reshaping the immunomicroenvironment of pancreatic ductal adenocarcinoma","volume":"21","author":"Liu","year":"2025","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.colsurfb.2025.115356_bib87","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1053\/j.gastro.2021.08.023","article-title":"Pancreatic tumor microenvironment factor promotes cancer stemness via SPP1-CD44 axis","volume":"161","author":"Nallasamy","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.colsurfb.2025.115356_bib88","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/gutjnl-2020-323014","article-title":"Exosome-delivered CD44v6\/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment","volume":"71","author":"Xie","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.colsurfb.2025.115356_bib89","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1172\/JCI92284","article-title":"Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer","volume":"127","author":"Liu","year":"2017","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.colsurfb.2025.115356_bib90","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1158\/1535-7163.MCT-17-1090","article-title":"iRGD-guided Tumor-penetrating Nanocomplexes for Therapeutic siRNA Delivery to Pancreatic Cancer","volume":"17","author":"Lo","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.colsurfb.2025.115356_bib91","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41388-024-03248-1","article-title":"Tissue factor promotes TREX1 protein stability to evade cGAS-STING innate immune response in pancreatic ductal adenocarcinoma","volume":"44","author":"Xue","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.colsurfb.2025.115356_bib92","doi-asserted-by":"crossref","DOI":"10.34133\/research.0673","article-title":"Isobutyrate confers resistance to inflammatory bowel disease through host-microbiota interactions in pigs","volume":"8","author":"Fang","year":"2025","journal-title":"Research"},{"key":"10.1016\/j.colsurfb.2025.115356_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.860767","article-title":"Intra-tumoral CD8+ T-cell infiltration and PD-L1 positivity in homologous recombination deficient pancreatic ductal adenocarcinoma","volume":"12","author":"Golesworthy","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.colsurfb.2025.115356_bib94","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1158\/1535-7163.MCT-06-0686","article-title":"Tumor-stroma interactions in pancreatic ductal adenocarcinoma","volume":"6","author":"Mahadevan","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.colsurfb.2025.115356_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23063314","article-title":"Matrix metalloproteinase 8 expression in a tumour predicts a favourable prognosis in pancreatic ductal adenocarcinoma","volume":"23","author":"Kaasinen","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2025.115356_bib96","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-22490-9","article-title":"Suppression of pancreatic ductal adenocarcinoma growth and metastasis by fibrillar collagens produced selectively by tumor cells","volume":"12","author":"Tian","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.colsurfb.2025.115356_bib97","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004784","article-title":"Toll-like receptor 7\/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer","volume":"10","author":"Ye","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.colsurfb.2025.115356_bib98","doi-asserted-by":"crossref","first-page":"12239","DOI":"10.1021\/acs.nanolett.4c02959","article-title":"A photoactivatable self-assembled nanoagonist for synergistic therapy against pancreatic ductal adenocarcinoma","volume":"24","author":"Xu","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.colsurfb.2025.115356_bib99","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.3748\/wjg.v20.i19.5808","article-title":"R. Andersson, Intervention on toll-like receptors in pancreatic cancer","volume":"20","author":"Vaz","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.colsurfb.2025.115356_bib100","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jconrel.2020.11.014","article-title":"Immunostimulatory nanoparticle incorporating two immune agonists for the treatment of pancreatic tumors","volume":"330","author":"Lorkowski","year":"2021","journal-title":"J. Control Release"},{"key":"10.1016\/j.colsurfb.2025.115356_bib101","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.3748\/wjg.v30.i19.2575","article-title":"Novel lactylation-related signature to predict prognosis for pancreatic adenocarcinoma","volume":"30","author":"Peng","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.colsurfb.2025.115356_bib102","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ymthe.2023.10.024","article-title":"mRNA vaccines and their delivery strategies: a journey from infectious diseases to cancer","volume":"32","author":"Malla","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.colsurfb.2025.115356_bib103","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1021\/acs.bioconjchem.4c00379","article-title":"Suppressing pancreatic cancer survival and immune escape via nanoparticle-modulated STING\/STAT3 axis regulation","volume":"35","author":"Li","year":"2024","journal-title":"Bioconj. Chem."},{"key":"10.1016\/j.colsurfb.2025.115356_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21858-1","article-title":"Tumor-penetrating therapy for \u03b25 integrin-rich pancreas cancer","volume":"12","author":"Hurtado de Mendoza","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.colsurfb.2025.115356_bib105","first-page":"118","article-title":"A widespread viral entry mechanism: the C-end rule motif-neuropilin receptor interaction","author":"Balistreri","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.colsurfb.2025.115356_bib106","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.molcel.2021.03.004","article-title":"Convergence of mammalian RQC and C-end rule proteolytic pathways via alanine tailing","volume":"81","author":"Thrun","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.colsurfb.2025.115356_bib107","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1021\/acs.jcim.3c01071","article-title":"Molecular view on the iRGD peptide binding mechanism: implications for integrin activity and selectivity profiles","volume":"63","author":"D'Amore","year":"2023","journal-title":"J. Chem. Inf. Model"},{"key":"10.1016\/j.colsurfb.2025.115356_bib108","article-title":"K29-linked ubiquitination of transcription regulators controls cell proliferation in the unfolded protein response","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.colsurfb.2025.115356_bib109","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.semcancer.2019.08.013","article-title":"Nanomaterials multifunctional behavior for enlightened cancer therapeutics","volume":"69","author":"Raju","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.colsurfb.2025.115356_bib110","article-title":"Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer","volume":"6","author":"Aznar","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.colsurfb.2025.115356_bib111","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4062\/biomolther.2024.029","article-title":"Tumor stroma as a therapeutic target for pancreatic ductal adenocarcinoma","volume":"32","author":"Lee","year":"2024","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.colsurfb.2025.115356_bib112","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.actbio.2020.04.053","article-title":"Monitoring matrix remodeling in the cellular microenvironment using microrheology for complex cellular systems","volume":"111","author":"Hafner","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.colsurfb.2025.115356_bib113","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.addr.2015.11.019","article-title":"ECM and ECM-like materials - biomaterials for applications in regenerative medicine and cancer therapy","volume":"97","author":"Hinderer","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.colsurfb.2025.115356_bib114","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41587-019-0392-8","article-title":"Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas","volume":"38","author":"Moncada","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.colsurfb.2025.115356_bib115","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.ccell.2025.06.020","article-title":"Integrated single-cell and spatial transcriptomics uncover distinct cellular subtypes involved in neural invasion in pancreatic cancer","volume":"43","author":"Chen","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.colsurfb.2025.115356_bib116","doi-asserted-by":"crossref","first-page":"27382","DOI":"10.1021\/jacs.4c06402","article-title":"ClickRNA-PROTAC for tumor-selective protein degradation and targeted cancer therapy","volume":"146","author":"Teng","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.colsurfb.2025.115356_bib117","doi-asserted-by":"crossref","first-page":"56718","DOI":"10.1021\/acsami.4c11188","article-title":"Embedded bioprinting of tumor-scale pancreatic cancer-stroma 3D models for preclinical drug screening","volume":"16","author":"Monteiro","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.colsurfb.2025.115356_bib118","doi-asserted-by":"crossref","first-page":"676","DOI":"10.18063\/ijb.v9i3.676","article-title":"Bioprinting of hydrogel beads to engineer pancreatic tumor-stroma microtissues for drug screening","volume":"9","author":"Huang","year":"2023","journal-title":"Int. J. Bioprint"},{"key":"10.1016\/j.colsurfb.2025.115356_bib119","doi-asserted-by":"crossref","DOI":"10.34133\/cbsystems.0011","article-title":"Microfluidic-assisted caenorhabditis elegans sorting: current status and future prospects","volume":"4","author":"Yuan","year":"2023","journal-title":"Cyborg Bionic Syst."},{"key":"10.1016\/j.colsurfb.2025.115356_bib120","doi-asserted-by":"crossref","DOI":"10.34133\/cbsystems.0107","article-title":"Advances in the model structure of in vitro vascularized organ-on-a-chip","volume":"5","author":"Yin","year":"2024","journal-title":"Cyborg Bionic Syst."},{"key":"10.1016\/j.colsurfb.2025.115356_bib121","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-022-01476-9","article-title":"Nanoparticles mediated tumor microenvironment modulation: current advances and applications","volume":"20","author":"Raju","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.colsurfb.2025.115356_bib122","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202407353","article-title":"Discovery of A G-Quadruplex unwinder that unleashes the translation of G-quadruplex-containing mRNA without inducing DNA damage","volume":"63","author":"Teng","year":"2024","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"10.1016\/j.colsurfb.2025.115356_bib123","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-019-0837-z","article-title":"Aspartate \u03b2-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway","volume":"12","author":"Ogawa","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.colsurfb.2025.115356_bib124","doi-asserted-by":"crossref","DOI":"10.34133\/cbsystems.0022","article-title":"Carbon-based stimuli-responsive nanomaterials: classification and application","volume":"4","author":"Zhao","year":"2023","journal-title":"Cyborg Bionic Syst."},{"key":"10.1016\/j.colsurfb.2025.115356_bib125","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303149","article-title":"Bioactivable STING nanoagonists to synergize NIR-II Mild photothermal therapy primed robust and long-term anticancer immunity","volume":"35","author":"Ma","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.colsurfb.2025.115356_bib126","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12951-021-01226-3","article-title":"Extracellular matrix-degrading STING nanoagonists for mild NIR-II photothermal-augmented chemodynamic-immunotherapy","volume":"20","author":"Zhan","year":"2022","journal-title":"J. Nanobiotechnol."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092777652500863X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092777652500863X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T15:54:35Z","timestamp":1769874875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092777652500863X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":126,"alternative-id":["S092777652500863X"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2025.115356","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ECM-responsive nanomedicine to enhance immunotherapy in pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2025.115356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115356"}}